510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Aart Malar Implant

K021419510(k) TraditionalCleared Jul 2, 200260-day reviewClass II21 CFR 878.3550Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aesthetic and Reconstructive Technologies, Inc. · LZK Implant, Malar

Cleared on Jul 2, 2002 after a 60-day review. The FDA summary names its predicate without a number. It has been recalled once.

Decided
Jul 2, 2002
Review
60 days
Class
Class II
Product code
LZK
Recalls
1
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K021419Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Allied Biomedical Corporation Dmlastic Anatomical Malar Implants
Named without a submission number
—
*—Seare Biomedical Corp. Malar Implants
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 26, 2025Class IIZ-0947-2026No Marketing ApplicationDue to manufactured products that deviated from established specifications and being distributed without obtaining the required FDA premarket approvals or clearances.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LZK devices

LZK Implant, Malar: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LZK

FDA has decided no LZK device since 2007.

Median 510(k) review, days · LZK

Too few LZK 510(k)s in any year since 2007 to give a median.

Recalls per year · LZK

1in 2025

2007: 32025: 1
2007high 3 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZK

1in 2022

2007: 102008: 52009: 22010: 42011: 42012: 72013: 12014: 12015: 32016: 12017: 32018: 22019: 22020: 12021: 12022: 1
2007high 10 (2007) · low 0 (2023)2025

MAUDE reports naming product code LZK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—310
20080—05
20090—02
20100—04
20110—04
20120—07
20130—01
20140—01
20150—03
20160—01
20170—03
20180—02
20190—02
20200—01
20210—01
20220—01
20230—00
20240—00
20250—10
20260—0—

What is it indicated for?

The intended use of the AART Malar Implant is for augmentation or reconstruction of the cheek areas of the face.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K021419: Aart Malar Implant.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K021419

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026